Wedbush Securities’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Wedbush Securities’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$202K	Sell	1,005 -81	-7%	-$16.8K	0.01%	1131
2025 Q4	$224K	Buy	+1,086	New	+$217K	0.01%	1044
2022 Q1	–	Sell	-1,384	Closed	-$224K	–	1133
2021 Q4	$224K	Hold	1,384	–	–	0.01%	1008
2021 Q3	$230K	Sell	1,384 -127	-8%	-$21.7K	0.01%	995
2021 Q2	$261K	Sell	1,511 -190	-11%	-$31.4K	0.01%	927
2021 Q1	$273K	Buy	1,701 +118	+7%	+$20.2K	0.02%	852
2020 Q4	$266K	Sell	1,583 -22	-1%	-$3.57K	0.02%	689
2020 Q3	$252K	Sell	1,605 -520	-24%	-$85K	0.02%	691
2020 Q2	$357K	Buy	2,125 +500	+31%	+$78.5K	0.03%	542
2020 Q1	$213K	Sell	1,625 -45	-3%	-$6.41K	0.03%	664
2019 Q4	$248K	Sell	1,670 -239	-13%	-$32.8K	0.02%	753
2019 Q3	$236K	Sell	1,909 -200	-9%	-$26.6K	0.02%	754
2019 Q2	$297K	Buy	2,109 +442	+27%	+$61K	0.03%	632
2019 Q1	$251K	Buy	+1,667	New	+$240K	0.03%	670
2018 Q4	–	Sell	-1,268	Closed	-$201K	–	866
2018 Q3	$201K	Buy	+1,268	New	+$192K	0.02%	778
2016 Q4	–	Sell	-3,951	Closed	-$394K	–	838
2016 Q3	$394K	Sell	3,951 -305	-7%	-$29.9K	0.06%	406
2016 Q2	$381K	Sell	4,256 -140	-3%	-$12.9K	0.06%	362
2016 Q1	$385K	Sell	4,396 -2,188	-33%	-$193K	0.07%	326
2015 Q4	$744K	Buy	6,584 +46	+0.7%	+$4.95K	0.13%	171
2015 Q3	$662K	Sell	6,538 -1,338	-17%	-$159K	0.13%	175
2015 Q2	$977K	Buy	7,876 +856	+12%	+$103K	0.18%	129
2015 Q1	$830K	Buy	7,020 +1,862	+36%	+$211K	0.14%	161
2014 Q4	$526K	Sell	5,158 -214	-4%	-$20.9K	0.08%	254
2014 Q3	$493K	Buy	5,372 +662	+14%	+$57.4K	0.08%	268
2014 Q2	$388K	Buy	4,710 +195	+4%	+$14.9K	0.06%	321
2014 Q1	$346K	Buy	4,515 +377	+9%	+$29.4K	0.06%	325
2013 Q4	$286K	Buy	4,138 +575	+16%	+$37.7K	0.07%	350
2013 Q3	$231K	Buy	+3,563	New	+$225K	0.06%	381

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return

Wedbush Securities's FBT Position: Q1 2026 in Review

Wedbush Securities reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 7.5% in Q1 2026, selling an estimated $16.8K and leaving 1,005 shares worth $202K. The position accounts for 0.01% of the portfolio, ranked #1131.

Wedbush Securities first reported a position in FBT in Q3 2013 and has held it in 28 quarters since. The position peaked at $977K in Q2 2015. 307 funds tracked by Wall St. Rank hold FBT as of Q1 2026.

Wedbush Securities held 1,005 shares of First Trust NYSE Arca Biotechnology Index Fund worth $202K as of Q1 2026.
Wedbush Securities sold 81 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2026, an estimated $16.8K.
First Trust NYSE Arca Biotechnology Index Fund made up 0.01% of Wedbush Securities's portfolio in Q1 2026, its #1131 holding.
Wedbush Securities first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q3 2013 and has held it in 28 quarters since.
Wedbush Securities's First Trust NYSE Arca Biotechnology Index Fund position peaked at $977K in Q2 2015.
307 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.

Based on Wedbush Securities's 13F filing for Q1 2026, filed 21 Apr 2026.